Copyright
©The Author(s) 2021.
World J Clin Cases. Jun 26, 2021; 9(18): 4654-4667
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4654
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4654
Table 1 Demography, clinical manifestations and comorbidities of coronavirus disease 2019 patients
| Overall, n = 91 | Shiraz, n = 23 | Mashhad, n = 13 | Dezful, n = 35 | Rasht, n = 20 | |
| Sex | |||||
| Male | 51 (56) | 13 (56) | 2 (15) | 21 (60) | 15 (75) |
| Female | 40 (44) | 10 (44) | 11 (85) | 14 (40) | 5 (25) |
| Average age | 51 | 51 | 52 | 53 | 48 |
| BMI > 25 kg/m2, % (n) | 26.3 (78) | 26 (20) | 25.9 (12) | 26.6 (29) | 26.4 (17) |
| Pneumonia % (n) | 100 (91) | 100 (23) | 100 (13) | 100 (35) | 100 (20) |
| Cough | 84.6 (77) | 82.6 (19) | 69.2 (9) | 88.5 (31) | 90 (18) |
| Shortness of breath | 71.4 (65) | 69.5 (16) | 53.8 (7) | 80 (28) | 70 (14) |
| Fever | 52.7 (48) | 73.9 (17) | 30.7 (4) | 42.8 (15) | 60 (12) |
| Loss of appetite | 43.9 (40) | 47.8 (11) | 38.4 (5) | 48.5 (17) | 35 (7) |
| Nausea | 42.8 (39) | 56.5 (13) | 23 (3) | 42.8 (15) | 40 (8) |
| Fatigue | 41.7 (38) | 39.1 (9) | 30.7 (4) | 60 (21) | 20 (4) |
| Myalgia | 32.9 (30) | 21.7 (5) | 23 (3) | 51.4 (18) | 20 (4) |
| Diarrhea | 31.8 (29) | 34.7 (8) | 38.4 (5) | 28.5 (10) | 30 (6) |
| Vomiting | 26.3 (24) | 47.8 (11) | 15.3 (2) | 22.8 (8) | 15 (3) |
| Abdominal pain | 12 (11) | 8.7 (2) | 2 (3) | 11.4 (4) | 10 (2) |
| GI bleed | 5.4 (5) | 0 | 0 | 8.5 (3) | 10 (2) |
| Cholecystitis | 3.3 (3) | 4.3 (1) | 0 | 2.8 (1) | 5 (1) |
| Hepatomegaly | 3.3 (3) | 4.3 (1) | 0 | 5.7 (2) | 0 |
| Alcohol | 2.2 (2) | 0 | 0 | 5.7 (2) | 0 |
| Cardiac disease | 28.5 (26) | 43.4 (10) | 7.6 (1) | 31.4 (11) | 20 (4) |
| Hypertension | 28.5 (26) | 13 (3) | 30.7 (4) | 37.1 (13) | 30 (6) |
| Diabetes | 25.2 (23) | 34.7 (8) | 7.6 (1) | 22.8 (8) | 30 (6) |
| Luminal GI disease | 23 (21) | 26 (6) | 23 (3) | 17.1 (6) | 30 (6) |
| Immunocompromised | 20.8 (19) | 17.3 (4) | 46.1 (6) | 20 (7) | 10 (2) |
| Smoking | 19 (17) | 10 (2) | 15.3 (2) | 28.1 (10) | 15.7 (3) |
| H/O liver disease | 10.9 (10) | 8.7 (2) | 15.3 (2) | 11.4 (4) | 10 (2) |
| H/O GERD/PUD | 8.7 (8) | 13 (3) | 0 | 5.7 (2) | 15 (3) |
| H/O alcohol abuse | 1.1 (1) | 0 | 0 | 2.8 (1) | 0 |
| H/O IBD | 1.1 (1) | 0 | 0 | 2.8 (1) | 0 |
| Abnormal CT chest | 91.8 (79) | 85.7 (19) | 84.6 (11) | 96.9 (32) | 94.7 (19) |
| Abnormal O2 sat in admission | 64.8 (59) | 43.4 (10) | 61.5 (8) | 77.1 (27) | 70 (14) |
| Abnormal O2 sat at 24 h day 1 | 42.8 (39) | 30.4 (7) | 38.4 (5) | 51.4 (18) | 45 (9) |
| Abnormal O2 sat at 48 h day 2 | 39 (34) | 17.3 (4) | 40 (4) | 50 (17) | 45 (9) |
| Abnormal O2 sat at 72 h day 3 | 37.9 (33) | 26 (6) | 30 (3) | 47 (16) | 40 (8) |
| Abnormal ALT | 27.4 (25) | 30.4 (7) | 15.3 (2) | 28.5 (10) | 30.4 (6) |
| Abnormal AST | 23 (21) | 26 (6) | 15.3 (2) | 22.8 (8) | 25 (5) |
| Abnormal albumin | 22 (20) | 13 (3) | 15.3 (2) | 31.4 (11) | 20 (4) |
| Abnormal creatinine | 43(36) | 41(9) | 42(5) | 43(15) | 47(7) |
| Hydroxychloroquine/chloroquine | 86.8 (79) | 91.3 (21) | 69.2 (9) | 94.2 (33) | 80 (16) |
| Mechanical ventilation | 18.6 (17) | 17.3 (4) | 38.4 (5) | 11.4 (4) | 20 (4) |
| ICU transfer | 15.3 (14) | 17.3 (4) | 15.3 (2) | 17.1 (6) | 10 (2) |
| Admitted to floor or ICU | 14.2 (13) | 13 (3) | 15.3 (2) | 17.1 (6) | 10 (2) |
| Vasopressor support | 9.8 (9) | 8.7 (2) | 0 | 17.1 (6) | 5 (1) |
| Glucocorticoids | 9.8 (9) | 8.7 (2) | 23 (3) | 11.4 (4) | 0 |
| Nursing home patient | 4.4 (4) | 4.3 (1) | 7.6 (1) | 2.8 (1) | 5 (1) |
| Health worker | 2.2 (2) | 4.3 (1) | 0 | 2.8 (1) | 0 |
| Known exposure | 10.9 (10) | 13 (3) | 15.3 (2) | 11.4 (4) | 5 (1) |
| Death | 14.2 (13) | 13 (3) | 15.3 (2) | 17.1 (6) | 10 (2) |
- Citation: Mokarram P, Dalivand MM, Pizuorno A, Aligolighasemabadi F, Sadeghdoust M, Sadeghdoust E, Aduli F, Oskrochi G, Brim H, Ashktorab H. Clinical characteristics, gastrointestinal manifestations and outcomes of COVID-19 patients in Iran; does the location matters? World J Clin Cases 2021; 9(18): 4654-4667
- URL: https://www.wjgnet.com/2307-8960/full/v9/i18/4654.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i18.4654